WinstonWınston
Medinotec logo

Medinotec

MDNC
Winston Score
Winston looking sleepy
No score yet — Winston is napping.
We couldn’t gather enough financial data to score this stock reliably.

Medinotec Inc. (MDNC) is a small medical device company focused on developing tools used during surgical procedures. The company works on products designed to help surgeons perform minimally invasive operations, meaning procedures that require smaller cuts and lead to faster patient recovery. Its main customers are hospitals and surgical centers, placing it in the broader medical technology industry.

Medinotec generates revenue primarily through the sale and licensing of its medical devices to healthcare providers. The company appears to operate mainly in the United States, and as a smaller-cap firm, it likely has a limited commercial footprint compared to larger competitors like Medtronic or Stryker. The key risk for Medinotec is that it must successfully navigate regulatory approval from the FDA for its products before it can sell them widely, and any delays or rejections in that process could significantly slow its growth.

Winston Score History

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
N/A
no trend
Data not available
Operating Margin
N/A
no trend
Data not available
ROCE
N/A
no trend
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
N/A
no trend
Data not available
EPS YoY
N/A
no trend
Data not available
EPS Consistency
N/A
no trend
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
N/A
no trend
Data not available
FCF Margin
N/A
no trend
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
N/A
no trend
Data not available
Interest Cover
N/A
no trend
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
25.1x
no trend
Growth-priced — P/E 25.1

P/E above the market average. People are paying up for expected growth.

P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial